Tests airway pressure therapy in older veterans with lung disease and sleep apnea
Tests a breathing machine against usual care in older veterans with COPD and sleep apnea.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Detroit, United StatesSee the site
- Trial code
- Registry title
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- Status
- Recruiting
- People taking part
- 668 people, planned
- Started
- 1 Dec 2020
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Positive airway pressure
- Conservative care (control arm)
- Record updated
- 5 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 60 or older who have both moderate-to-severe obstructive sleep apnea and moderate-to-severe COPD (overlap syndrome). It tests positive airway pressure therapy.
- Age
- 60 years or older
- Sex
- Men and women can join.
- Disease stage
- Moderate-to-severe obstructive sleep apnea (AHI 20 per hour or more on an in-lab sleep study) together with moderate-to-severe COPD, based on lung function tests, and a past smoking history of more than 10 pack-years.
- Earlier treatment
- People must be on a stable treatment plan for COPD. People who are using or have used PAP or an oral appliance cannot join.
Main reasons for not taking part
- Current or past treatment with PAP or an oral appliance
- Central sleep apnea (central apnea index above 5 per hour and 50% of AHI)
- Known primary neuromuscular disease, neurodegenerative disorder or traumatic brain injury
- Severe sleepiness (Epworth score above 16) or a near-miss or accident due to sleepiness in the past 12 months
- Long-term oxygen therapy for more than 12 hours a day, or pregnancy
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- OSA with moderate-to-severe disease, AHI 20 per hour by in-lab polysomnography with concomitant moderate-severe COPD based on pulmonary function tests (PFTS) and with past significant history (>10 pack-years) of smoking
- Male or female gender
- Age greater than or equal to 60 years
- Stable treatment regimen for COPD
Who cannot take part
- Current or prior treatment with PAP or oral appliance
- Epworth sleepiness score >16 (severe sleepiness) or a near-miss or prior automobile accident due to sleepiness within the past 12 months
- On long-term oxygen therapy prior to start of study, more than 12 hr/day
- Consumption of >3 alcoholic beverages per day or current use of some illicit drugs, as these may contribute to cognitive deficits
- Patients receiving hospice care
- Known primary neuromuscular diseases
- Disorders that may impact cognitive function including:; neurodegenerative disorders; traumatic brain injury
- untreated PTSD and/or history of learning disability
- Patient is actively suicidal due to depression, unstable mental health condition
- Narcolepsy is the primary sleep disorder, with requirement of stimulant medications
- Central sleep apnea defined as central apnea index >5 per hour and comprising 50% of AHI
- Medicines that may cause or alter sleepiness: sedative hypnotics, or stimulants as these may alter the results
- Employed as a commercial driver or operating heavy machinery
- Patients is unable to use either a nasal or face mask (e.g., facial trauma, claustrophobia)
- Patients who cannot give informed consent
- Pregnant women due to unknown risks
Where in United States
- John D. Dingell VA Medical Center, Detroit, MIDetroit, United StatesContact: Ruchi Rastogi, MSTaking people
About the trial
What the trial wants to find out
Obstructive sleep apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD) are highly prevalent chronic respiratory diseases in the Veteran population. OSA co-occurring with COPD, known as Overlap Syndrome (OVS), is a complex chronic medical condition associated with grave consequences. OVS is highly prevalent in Veterans. Veterans with OVS may be at increased risk for cognitive deficits, poor sleep quality as well as a reduced quality of life (QoL). The overall objective is to study the effects of positive airway pressure therapy on clinical outcomes in patients with OVS.
The 2 groups in the trial
- Conservative care (control arm)Other group
Eligible OVS patients will receive conservative care/usual care with education about sleep apnea and sleep hygiene via handouts and video instructions. This is the control arm.
- PAP therapy armExisting treatment, for comparison
PAP Therapy will be provided to eligible patients with OVS. This is the active therapy arm.
Treatment: Positive airway pressure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- Plain-language title
- Tests airway pressure therapy in older veterans with lung disease and sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 June 2026